Cent Eur J Public Health 2017, 25(4):313-320 | DOI: 10.21101/cejph.a4968

Prevalence and Trends of Metabolic Syndrome in Clients of Health Advice Centres During the Years 2003-2012

Tímea Ostrihoňová1, Kvetoslava Rimárová2, Janka Bérešová3, Silvia Kontrošová4, Erik Dorko2, Jana Diabelková2
1 General Hospital, Rimavská Sobota, Slovak Republic
2 Department of Public Health and Hygiene, Faculty of Medicine, Pavol Jozef Šafárik University in Košice, Košice, Slovak Republic
3 Regional Public Health Authority, Rimavská Sobota, Slovak Republic
4 Regional Public Health Authority, Banská Bystrica, Slovak Republic

Objective: Metabolic syndrome is a combination of clinical risk factors for cardiovascular disease as well as for diabetes. Metabolic syndrome arises from insulin resistance accompanied with abnormal adipose deposition. The aim of our cross-sectional time trends study was to characterize the prevalence of metabolic syndrome and its five risk determinants among the clients of Health Advice Centres of Regional Public Health Authorities in Slovakia. The study was stratified by gender and age groups during the 10 year period from 2003-2012.

Methods: Prevalence data were estimated in adults and children (≥ 10 years, N = 79,904) from the nationwide electronic database of Health Advice Centres of Regional Public Health Authorities in Slovak Republic "Test of healthy heart" from 2003 to 2012.

Results: The overall prevalence of metabolic syndrome was 30.2% in males and 26.6% in females, abdominal obesity was confirmed in 48.3% of males and 53.9% of females. Increased triglyceride level has higher prevalence among males (33.3%) compared to females (24.2%). Blood pressure (BP) values and fasting glucose values were significantly higher in males (58.2%) than females (41.9%). During the 10 year period from 2003 to 2012, we confirmed an increased trend in the age-adjusted prevalence of metabolic syndrome. Abdominal obesity and elevated triglycerides had also increased time trends prevalence in both sexes. The prevalence of people without risk determinants of metabolic syndrome had a time decreasing trend. A surprising finding is a decrease in the proportion of persons with suboptimal HDL-cholesterol. The proportion of people with elevated BP and glucose showed little change during the reporting period.

Conclusion: The increasing prevalence of metabolic syndrome, abdominal obesity, and elevated triglycerides highlights the urgency of addressing these health problems as a healthcare priority to reduce cardiovascular mortality in the Slovak Republic.

Keywords: metabolic syndrome, Slovak Republic, abdominal obesity, hypertriglyceridemia, hyperglycemia, hypertension, HDL cholesterol

Received: October 27, 2016; Revised: April 24, 2017; Published: December 30, 2017  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Ostrihoňová T, Rimárová K, Bérešová J, Kontrošová S, Dorko E, Diabelková J. Prevalence and Trends of Metabolic Syndrome in Clients of Health Advice Centres During the Years 2003-2012. Cent Eur J Public Health. 2017;25(4):313-320. doi: 10.21101/cejph.a4968. PubMed PMID: 29346856.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. World Health Organization. 2008-2013 Action plan for the global strategy for the prevention and control of noncommunicable diseases. Geneva: WHO; 2009.
    2. Mortality from heart disease and stroke. In: OECD. Health at a glance 2011: OECD Indicators. OECD Publishing; 2011. p. 28-9.
    3. Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988 Dec;37(12):1595-607. Go to original source... Go to PubMed...
    4. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Pt. 1, Diagnosis and classification of diabetes mellitus. Geneva: WHO; 1999.
    5. Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation. 2004;109(3):433-8. Go to original source... Go to PubMed...
    6. Balkau B, Charles MA; European Group for the Study of Insulin Resistance (EGIR). Comment on the provisional report from the WHO consultation. Diabet Med. 1999 May;16(5):442-3. Go to original source... Go to PubMed...
    7. Alberti KG, Zimmet P, Shaw J. The metabolic syndrome - a new worldwide definition. Lancet. 2005;366(9491):1059-62. Go to original source... Go to PubMed...
    8. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al.; International Diabetes Federation Task Force on Epidemiology and Prevention, National Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009 Oct 20;120(16):1640-5. Go to original source... Go to PubMed...
    9. Kassi E, Pervanidou P, Kaltsas G, Chrousos G. Metabolic syndrome: definitions and controversies. BMC Med. 2011 May 5;9:48. doi: 10.1186/1741-7015-9-48. Go to original source... Go to PubMed...
    10. Haffner SM, Valdez RA, Hazuda HP, Mitchell BD, Morales PA, Stern MP. Prospective analysis of the insulin-resistance syndrome (syndrome X). Diabetes. 1992;41(6):715-22. Go to original source... Go to PubMed...
    11. Isomaa B, Almgren P, Tuomi T, Forsén B, Lahti K, Nissén M, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care. 2001 Apr;24(4):683-9. Go to original source... Go to PubMed...
    12. Trevisan M, Liu J, Bahsas FB, Menotti A. Syndrome X and mortality: a population-based study. Am J Epidemiol.1998;148(10):958-66. Go to original source... Go to PubMed...
    13. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA. 2002;287(3):356-9. Go to original source... Go to PubMed...
    14. Simmons RK, Alberti KG, Gale EA, Colagiuri S, Tuomilehto J, Qiao Q, et al. The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation. Diabetologia. 2010;53(4):600-60. Go to original source... Go to PubMed...
    15. International Diabetes Federation. The IDF consensus definition of the metabolic syndrome in children and adolescents. Brussels: IDF; 2007.
    16. Avdičová M. Methodological handbook for work in Health Advice Centres: a manual for Health Advice Centres of the National Institute of Public Health in Slovakia. Bratislava: Ministry of Health of the Slovak Republic; 2000. (In Slovak.)
    17. International Diabetes Federation: The IDF consensus worldwide definition of the metabolic syndrome. Brussels: IDF; 2006.
    18. Desroches S, Lamarche B. The evolving definitions and increasing prevalence of the metabolic syndrome. Appl Physiol Nutr Metab. 2007;32(1):23-32. Go to original source... Go to PubMed...
    19. Kolovou GD, Anagnostopoulou KK, Salpea KD, Mikhailidis DP. The prevalence of metabolic syndrome in various populations. Am J Med Sci. 2007;333(6):362-71. Go to original source... Go to PubMed...
    20. Cameron AJ, Shaw JE, Zimmet PZ. The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metab Clin North Am. 2004;33(2):351-75. Go to original source... Go to PubMed...
    21. Nevrlka J, Souček M. Metabolic syndrome and hypertension. Remedia. 2006;16(2):146-51. (In Czech.)
    22. Mokáň M, Galajda P, Prídavková D, Tomášková V, Šutarík Ľ, Kručinská Ľ, et al. Prevalence of diabetes mellitus and metabolic syndrome in Slovakia. Diabetes Obes. 2006;6(12):10-6. (In Slovak.)
    23. Lietava J, Kosmálová V, Turek P, Šomlo P, Dukát A. Project NEMESYS: screening for metabolic syndrome in outpatients. Int Med. 2006;6(12):685-9. (In Slovak.)
    24. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. 2003;163(4):427-36. Go to original source... Go to PubMed...
    25. Azizi F, Salehi P, Etemadi A, Zahedi-Asl S. Prevalence of metabolic syndrome in an urban population: Tehran Lipid and Glucose Study. Diab Res Clin Pract. 2003;61(1):29-37. Go to original source...
    26. Balkau B, Vernay M, Mhamdi L, Novak M, Arondel D, Vol S, et al. The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French D.E.S.I.R. study. Diabet Metab. 2003;29(5):526-32. Go to original source...
    27. Beltrán-Sánchez H, Harhay MO, Harhay MM, Mcelligott S. Prevalence and trends of metabolic syndrome in the adult U.S. population, 1999-2010. J Am Coll Cardiol. 2013;62(8):697-703 Go to original source... Go to PubMed...

    Return to the content